|
|
|
|
The pharmacokinetics of oral ketoprofen in patients after gastric resection
|
|
|
|
|
|
|
|
نویسنده
|
porażka j. ,karbownik a. ,murawa d. ,spychała a. ,firlej m. ,grabowski t. ,murawa p. ,grześkowiak e. ,szałek e.
|
|
منبع
|
pharmacological reports - 2017 - دوره : 69 - شماره : 2 - صفحه:296 -299
|
|
چکیده
|
Background total and partial gastric resection may affect the pharmacokinetics of drugs,especially orally administered a few days after surgery. ketoprofen is a non-steroidal anti-inflammatory drug (nsaid) broadly used to treat postoperative pain,including patients after gastric resection. the aim of the research was to analyse the pharmacokinetics (pk) of orally administered ketoprofen in patients after gastrectomy. methods the research was carried out on two groups of patients after total (tg; roux-y procedure) and partial (pg; billroth ii procedure) gastrectomy. the patients in group tg (n = 15; mean [sd] age 61.86 [14.15] years; and bmi 24.20 [3.73] kg/m2) and group pg (n = 5; mean [sd] age 62.40 [16.80] years; and bmi 23.98 [3.45] kg/m2) received ketoprofen in a single oral dose of 100 mg. the measurement of ketoprofen plasma concentrations was made by means of the hplc (high performance liquid chromatography) method. results the pk parameters in group tg and pg were as follows: maximum plasma concentration (cmax),3.42 [0.99] and 4.66 [0.81] mg/l (p = 0.0220); area under the plasma concentration-time curve from zero to infinity (auc0-∞),9.12 [2.78] and 9.17 [2.87] mg × h/ml (p = 0.9734); area under the first moment curve from zero to the time of infinity (aumc0-∞),25.95 [8.52] and 26.53 [11.43] mg × h2/l (p = 0.9056); time to reach maximum concentration (tmax),0.47 [0.25] and 0.55 [0.27] h (p = 0.5327),respectively. conclusions lower concentrations of ketoprofen in patients after gastrectomy suggest that it might be necessary to apply higher dose of the analgesic. © 2016
|
|
کلیدواژه
|
Ketoprofen; Partial gastrectomy; Pharmacokinetics; Total gastrectomy
|
|
آدرس
|
department of clinical pharmacy and biopharmacy,karol marcinkowski university of medical sciences,poznań,61-861, Poland, department of clinical pharmacy and biopharmacy,karol marcinkowski university of medical sciences,poznań,61-861, Poland, 1 st department of surgical oncology and general surgery,wielkopolska cancer centre,poznań,61-866,poland,college of health,beauty care and education,faculty of cosmetology and educational sciences,poznań,60-133, Poland, 1 st department of surgical oncology and general surgery,wielkopolska cancer centre,poznań,61-866, Poland, department of clinical pharmacy and biopharmacy,karol marcinkowski university of medical sciences,poznań,61-861, Poland, polpharma biologics,gdańsk,80-172, Poland, 1 st department of surgical oncology and general surgery,wielkopolska cancer centre,poznań,61-866, Poland, department of clinical pharmacy and biopharmacy,karol marcinkowski university of medical sciences,poznań,61-861, Poland, department of clinical pharmacy and biopharmacy,karol marcinkowski university of medical sciences,poznań,61-861, Poland
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|